Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | PKM | P14618 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.37 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL27753007 | 0.98 | POLB (0.39) | ALDH1A1POLBNPSR1TSHRMAPT | |
| SCHEMBL2050077 | 0.93 | CA1 (0.43) | ALDH1A1POLBNPSR1TSHRMAPT | |
| SCHEMBL2691616 | 0.91 | THRB (0.46) | ALDH1A1POLBNPSR1TSHRMAPT | |
| SCHEMBL3861059 | 0.91 | THRB (0.46) | ALDH1A1POLBNPSR1TSHRMAPT | |
| SCHEMBL1233379 | 0.91 | THRB (0.46) | ALDH1A1POLBNPSR1TSHRMAPT | |
| SCHEMBL29114387 | 0.91 | THRB (0.46) | ALDH1A1POLBNPSR1TSHRMAPT | |
| SCHEMBL5704701 | 0.91 | THRB (0.46) | ALDH1A1POLBNPSR1TSHRMAPT | |
| SCHEMBL197278 | 0.91 | THRB (0.46) | ALDH1A1POLBNPSR1TSHRMAPT | |
| SCHEMBL5704769 | 0.91 | THRB (0.46) | ALDH1A1POLBNPSR1TSHRMAPT | |
| SCHEMBL2691524 | 0.91 | THRB (0.46) | ALDH1A1POLBNPSR1TSHRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 689 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250346622-A1 | NOVEL OLIGOSACCHARIDE, MANUFACTURING INTERMEDIATE FOR NOVEL OLIGOSACCHARIDE, AND METHOD FOR MANUFACTURING THESE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2025-11-13 | — | — | US | claimed |
| EP-4585601-A1 | NOVEL OLIGOSACCHARIDE, PRODUCTION INTERMEDIATE FOR NOVEL OLIGOSACCHARIDE, PRODUCTION METHOD FOR NOVEL OLIGOSACCHARIDE, AND PRODUCTION METHOD FOR PRODUCTION INTERMEDIATE FOR NOVEL OLIGOSACCHARIDE | Daiichi Sankyo Company, Limited (JP) | 2025-07-16 | — | — | EP | claimed |
| CN-118085318-B | Chiral rare earth supermolecular spirochete complex with macroscopic helix chirality and preparation method thereof | 黑龙江大学 | 2025-06-03 | — | — | CN | claimed |
| CN-119965364-A | Electrolyte for lithium metal battery containing rare earth phosphate and lithium metal battery | 安徽盟维新能源科技有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119812482-A | Electrolyte, lithium metal battery and electronic device | 南方科技大学 | 2025-04-11 | — | — | CN | claimed |
| CN-118931340-A | Oil-resistant, corrosion-resistant and static-conducting polyurea coating as well as preparation method and application thereof | 华南理工大学 | 2024-11-12 | — | — | CN | claimed |
| EP-4424717-A1 | NOVEL OLIGOSACCHARIDE, MANUFACTURING INTERMEDIATE FOR NOVEL OLIGOSACCHARIDE, AND METHOD FOR MANUFACTURING THESE | Daiichi Sankyo Company, Limited (JP) | 2024-09-04 | — | — | EP | claimed |
| CN-118302451-A | Novel oligosaccharide, intermediate for producing the oligosaccharide, and process for producing the same | 第一三共株式会社 | 2024-07-05 | — | — | CN | claimed |
| CN-118281336-A | Electrolyte with trace lithium nitrate as additive and electrochemical device | 中科(宜兴)新材料研究有限公司 | 2024-07-02 | — | — | CN | claimed |
| CN-114614098-B | Electrolyte and battery | 珠海冠宇电池股份有限公司 | 2024-07-02 | — | — | CN | claimed |
| EP-1303258-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | AstraZeneca AB (SE) | 2003-04-23 | — | — | EP | claimed |
| EP-0828717-B1 | METHOD OF PREPARING 3-HALOALKYL-1H-PYRAZOLES | SEARLE & CO (US) | 2002-09-04 | — | — | EP | claimed |
| WO-2002003958-A1 | NOVEL AEROSOL FORMULATION CONTAINING A POLAR FLUORINATED MOLECULE | ASTRAZENECA AB (SE) | 2002-01-17 | — | — | WO | claimed |
| US-6235700-B1 | CLEANING | 3M INNOVATIVE PROPERTIES COMPANY | 2001-05-22 | — | — | US | claimed |
| US-5910597-A | Process for preparing 3-haloalkyl-1H-pyrazoles | G.D. SEARLE & CO. (US) | 1999-06-08 | — | — | US | claimed |
| US-5892053-A | Process for preparing 3-haloalkyl-1H-pyrazoles | G. D. SEARLE & CO. (US) | 1999-04-06 | — | — | US | claimed |
| CN-1190960-A | Method of preparing 3-haloalkyl-1H-pyrazoles | SEARLE & CO (US) | 1998-08-19 | — | — | CN | claimed |
| EP-0828717-A1 | METHOD OF PREPARING 3-HALOALKYL-1H-PYRAZOLES | G.D. SEARLE & CO. (US) | 1998-03-18 | — | — | EP | claimed |
| WO-1996037476-A1 | METHOD OF PREPARING 3-HALOALKYL-1H-PYRAZOLES | G.D. SEARLE & CO. (US) | 1996-11-28 | — | — | WO | claimed |
| US-3948741-A | FREE RADICAL INITIATED | TEXACO INC. (US) | 1976-04-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346622-A1 | NOVEL OLIGOSACCHARIDE, MANUFACTURING INTERMEDIATE FOR NOVEL OLIGOSACCHARIDE, AND METHOD FOR MANUFACTURING THESE | FUT6, FUT5, ST3GAL3 | ALDH1A1 450/4885POLB 4505/4885NPSR1 2685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.